Nautilus Biotechnology, Inc. (NAUT) Ownership

$0.88

north_east
$0.01 (1.55%)
Day's range
$0.86
Day's range
$0.92

Nautilus Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
AH CAPITAL MANAGEMENT, L.L.C. 11/14/2025 17.65 M $14.92 M   0.00% 13.99%
PERCEPTIVE ADVISORS LLC 11/14/2025 12.59 M $10.64 M   0.00% 9.98%
CERCANO MANAGEMENT LLC 11/07/2025 7.17 M $6.06 M   0.00% 5.68%
MADRONA VENTURE GROUP, LLC 10/31/2025 6.02 M $5.09 M   0.00% 4.77%
VANGUARD GROUP INC 11/07/2025 2.43 M $2.05 M   -2.14% 1.93%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 11/14/2025 2.21 M $1.87 M   0.00% 1.75%
AMAZON COM INC 11/04/2025 1.46 M $1.23 M   0.00% 1.15%
CLARIUS GROUP, LLC 10/14/2025 1.21 M $1.02 M   14.07% 0.96%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.01 M $851.37 K   62.55% 0.80%
MILLENNIUM MANAGEMENT LLC 11/14/2025 967.55 K $817.48 K   -8.45% 0.77%
TIKVAH MANAGEMENT LLC 11/14/2025 726.90 K $614.15 K   0.00% 0.58%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 553.60 K $467.86 K   0.00% 0.44%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 364.68 K $307.81 K   -33.78% 0.29%
CI PRIVATE WEALTH, LLC 11/14/2025 319.14 K $269.64 K   -26.69% 0.25%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 301.01 K $254.33 K   18.11% 0.24%
GSA CAPITAL PARTNERS LLP 11/07/2025 259.20 K $219.00 K   46.52% 0.21%
CITADEL ADVISORS LLC 11/14/2025 254.16 K $214.74 K   42.66% 0.20%
ALYESKA INVESTMENT GROUP, L.P. 11/17/2025 253.47 K $214.16 K   0.00% 0.20%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 243.27 K $203.00 K   251.51% 0.19%
BLACKROCK, INC. 11/12/2025 201.44 K $170.20 K   -67.97% 0.16%
HILLMAN CO 10/23/2025 200.00 K $168.98 K   0.00% 0.16%
STATE STREET CORP 11/14/2025 178.76 K $151.03 K   -1.58% 0.14%
JANE STREET GROUP, LLC 11/14/2025 148.19 K $125.20 K   -48.97% 0.12%
CREWE ADVISORS LLC 11/13/2025 136.05 K $114.95 K   100.00% 0.11%
SQUAREPOINT OPS LLC 11/14/2025 131.83 K $111.38 K   29.47% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 125.00 K $105.61 K   0.00% 0.10%
NORTHERN TRUST CORP 11/14/2025 117.84 K $99.56 K   -20.63% 0.09%
GOLDMAN SACHS GROUP INC 11/14/2025 117.72 K $99.46 K   -62.62% 0.09%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 51.67 K $43.65 K   -16.85% 0.04%
HSBC HOLDINGS PLC 11/13/2025 49.60 K $40.14 K   0.00% 0.04%
BARCLAYS PLC 11/12/2025 48.25 K $40.77 K   -16.93% 0.04%
XTX TOPCO LTD 11/14/2025 45.72 K $38.63 K   -30.92% 0.04%
FAYEZ SAROFIM & CO 11/14/2025 45.00 K $38.02 K   0.00% 0.04%
ASHTON THOMAS PRIVATE WEALTH, LLC 11/04/2025 45.00 K $38.02 K   100.00% 0.04%
PALUMBO WEALTH MANAGEMENT LLC 11/10/2025 42.12 K $35.59 K   1.09% 0.03%
PRESIDIO CAPITAL MANAGEMENT, LLC 11/07/2025 34.66 K $29.29 K   0.00% 0.03%
BADGLEY PHELPS WEALTH MANAGERS, LLC 11/04/2025 30.00 K $25.35 K   0.00% 0.02%
MORGAN STANLEY 11/14/2025 25.73 K $21.74 K   -52.86% 0.02%
VIRTU FINANCIAL LLC 11/14/2025 19.68 K $17.00 K   100.00% 0.02%
CAPROCK GROUP, LLC 11/06/2025 17.09 K $11.62 K   100.00% 0.01%
POINT72 ASIA (SINGAPORE) PTE. LTD. 11/14/2025 16.27 K $13.75 K   -50.05% 0.01%
CALLAN FAMILY OFFICE, LLC 11/04/2025 14.83 K $12.53 K   -69.67% 0.01%
VANGUARD CAPITAL WEALTH ADVISORS 10/30/2025 13.50 K $11.41 K   -15.63% 0.01%
FMR LLC 11/13/2025 8.66 K $7.32 K   -64.65% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 5.60 K $4.73 K   -74.04% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/14/2025 5.00 K $4.23 K   100.00% 0.00%
JPMORGAN CHASE & CO 11/26/2025 2.12 K $1.79 K   -8.85% 0.00%
ROYAL BANK OF CANADA 11/14/2025 1.82 K $1.00 K   -20.92% 0.00%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 1.47 K $1.24 K   -57.26% 0.00%
TD WATERHOUSE CANADA INC. 11/03/2025 1.00 K $830   0.00% 0.00%

Nautilus Biotechnology, Inc. institutional Ownership - FAQ's

During the previous two years, 83 institutional investors and hedge funds held shares of Nautilus Biotechnology, Inc.. The most heavily invested institutionals were:

AH Capital Management, L.L.C.: 17.65 M

PERCEPTIVE ADVISORS LLC: 12.59 M

Cercano Management LLC: 7.17 M

Madrona Venture Group, LLC: 6.02 M

VANGUARD GROUP INC: 2.43 M

Comprehensive Financial Management LLC: 2.21 M

45.88% of Nautilus Biotechnology, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 79.60 M shares in the last 24 months. This purchase volume represents approximately $70.26 M in transactions.